Advanced Biomed Inc.ADVB
Price (close)
$6.38
Market cap
—
P/E
—
Revenue (TTM)
—
Net income
$5.3M
Dividend yield
—
1-year total return
-32.1%
Net margin
—
Revenue growth
—
Debt / equity
—
What Advanced Biomed Inc. does.
in the State of Nevada. We operate through Advanced Biomed Taiwan and Advanced Biomed HK. Advanced Biomed Taiwan is responsible for the
main operation and the design and development of the company’s primary technologies and products. Since our establishment in 2014,
we have been focusing on the integration of multiple interdisciplinary technologies and established our own microfluidic technology platform.
Revenue and profit, by fiscal year.
| Fiscal year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net income | — | -$2.8M | -$3.3M |
| Free cash flow | — | -$2.2M | -$5.9M |
More on ADVB.
- Advanced Biomed Inc. summary
- Advanced Biomed Inc. financial statements
- Advanced Biomed Inc. key metrics
- Advanced Biomed Inc. health scores and style box
- Advanced Biomed Inc. earnings
- Advanced Biomed Inc. dividends
- Advanced Biomed Inc. valuation
- Advanced Biomed Inc. ownership and insiders
- Advanced Biomed Inc. peers
Figures from Advanced Biomed Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.